BIVI · Biovie Inc.
$2.39
+0.23 (+10.42%)
At close · Aug 31
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These circumstances raise substantial doubt on the Company's ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-K filed Aug 13, 2026
Market Cap
$16.29M
Shares
7.54M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Cuong Do | Chief Executive Officer and President | $860,149 |
| Joseph M. Palumbo | Chief Medical Officer | $666,051 |
| Joanne Wendy Kim | Chief Financial Officer and Corporate Secretary | $420,621 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Cuong Do | Chief Executive Officer and President | $777,082 |
| Joseph M. Palumbo | Chief Medical officer | $669,584 |
| Joanne Wendy Kim | Chief Financial Officer, Treasurer and Corporate Secretary | $339,252 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Cuong Do | Chief Executive Officer and President | $2,337,668 |
| Joseph M. Palumbo | Chief Medical officer | $1,090,499 |
| Joanne Wendy Kim | Chief Financial Officer, Treasurer and Corporate Secretary | $723,874 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Cuong Do | Chief Executive Officer and President | $4,542,821 |
| Joseph M. Palumbo | Chief Medical officer | $1,090,499 |
| Joanne Wendy Kim | Chief Financial Officer, Treasurer and Corporate Secretary | $944,999 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Cuong Do | Chief Executive Officer and President | $454,794 |
| Jonathan Adams | Former President and Chief Operating Officer | $270,721 |
| Joanne Wendy Kim | Chief Financial Officer, Treasurer and Corporate Secretary | $125,331 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kameel D. Farag | Board of Directors | Appointed | 2025-07-23 |
| Amy S. Chappell, MD, FAAN | Board of Directors | Appointed | 2025-07-23 |
| Dr. Robert Hariri | Board of Directors | Resigned | 2025-03-28 |
| Steve Gorlin | director | Resigned | 2024-07-30 |
| Jim Lang | Chairman of the Board | Appointed | 2023-03-06 |
| Terren S. Peizer | Chairman of the Board of Directors | Resigned | 2023-03-06 |
| Cuong V. Do | President and CEO | Appointed | 2021-04-27 |
| Cuong V. Do | President and Chief Executive Officer | Appointed | 2021-04-27 |
| Jonathan Adams | director | Resigned | 2020-06-22 |
| Sigmund Rogich | member of the Board | Appointed | 2020-06-22 |
| Steve Gorlin | member of the Board | Appointed | 2020-06-22 |
| Dr. Robert Hariri | member of the Board | Appointed | 2020-06-22 |
Key facts
CIK
1580149
CUSIP
09074F504
13F (30d)
38 filings
36 filers
Visit website
Investor relations